p35は,サイクリン依存キナーゼ5の神経特異的な調節サブユニットです
L H Tsai1, I Delalle, V S Caviness
1Massachusetts General Hospital Cancer Center, Charlestown 02129.
Nature
|September 29, 1994
まとめ
研究者らは,脳組織に特異的にサイクリン依存キナーゼ5 (Cdk5) を活性化する新しい調節サブユニットであるp35を特定しました. この発見は,Cdk5を説明する.
科学分野:
- 神経科学は神経科学である.
- 分子生物学は分子生物学である.
- バイオケミストリー バイオケミストリー
背景:
- サイクリン依存キナーゼ5 (Cdk5) は,細胞周期調節体であるCdc2に構造的に類似しています.
- Cdk5タンパク質は脳と丸に豊富に存在するが,そのキナーゼ活性性は脳内でのみ検出される.
- 細胞系におけるCdk5キナーゼ活性の欠如は,規制サブユニットの関与を示唆した.
研究 の 目的:
- 脳内のCdk5活性化に責任を負う規制サブユニットを特定し,特徴づけること.
- ニューロンのCdk5活動におけるこのサブユニットの役割を調査する.
主な方法:
- 新種のタンパク質のクローン化と特徴づけ, p35.
- 異なる組織におけるp35発現パターンの分析.
- p35とCdk5.5との間のインビヴォ関連研究
- p35.5の存在下におけるCdk5キナーゼ活性測定
主要な成果:
- Cdk5の新しい規制サブユニットであるp35が特定されました.
- p35はニューロン細胞特異的な発現を示す.
- p35は体内でCdk5と物理的に結合し,そのキナーゼ活性を強力に活性化します.
結論:
- p35は,Cdk5.5のニューロン特異的活性化剤である.
- p35は,サイクリン依存キナーゼのための新しい規制サブユニットのクラスを表しています.
- Cdk5/p35複合体は,脳の特定の機能に不可欠です.
関連する概念動画
01:45Positive Regulator Molecules
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
01:23Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
02:39Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
00:50Anaphase Promoting Complex
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...